Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma.
Hwang JJ, Kuruvilla J, Mendelson D, Pishvaian MJ, Deeken JF, Siu LL, Berger MS, Viallet J, Marshall JL. Hwang JJ, et al. Among authors: pishvaian mj. Clin Cancer Res. 2010 Aug 1;16(15):4038-45. doi: 10.1158/1078-0432.CCR-10-0822. Epub 2010 Jun 10. Clin Cancer Res. 2010. PMID: 20538761 Free PMC article. Clinical Trial.
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.
Pishvaian MJ, Slack R, Koh EY, Beumer JH, Hartley ML, Cotarla I, Deeken J, He AR, Hwang J, Malik S, Firozvi K, Liu M, Elston B, Strychor S, Egorin MJ, Marshall JL. Pishvaian MJ, et al. Cancer Chemother Pharmacol. 2012 Dec;70(6):843-53. doi: 10.1007/s00280-012-1969-9. Epub 2012 Sep 27. Cancer Chemother Pharmacol. 2012. PMID: 23014737 Free PMC article. Clinical Trial.
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies.
Deeken JF, Slack R, Weiss GJ, Ramanathan RK, Pishvaian MJ, Hwang J, Lewandowski K, Subramaniam D, He AR, Cotarla I, Rahman A, Marshall JL. Deeken JF, et al. Among authors: pishvaian mj. Cancer Chemother Pharmacol. 2013 Mar;71(3):627-33. doi: 10.1007/s00280-012-2048-y. Epub 2012 Dec 30. Cancer Chemother Pharmacol. 2013. PMID: 23274395 Free PMC article. Clinical Trial.
Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Gurka MK, et al. Among authors: pishvaian mj. Radiat Oncol. 2013 Mar 1;8:44. doi: 10.1186/1748-717X-8-44. Radiat Oncol. 2013. PMID: 23452509 Free PMC article. Clinical Trial.
Future of targeted agents in metastatic colorectal cancer.
Burotto M, Hartley ML, Marshall JL, Pishvaian MJ. Burotto M, et al. Among authors: pishvaian mj. Colorectal Cancer. 2012 Oct;1(5):10.2217/crc.12.52. doi: 10.2217/crc.12.52. Colorectal Cancer. 2012. PMID: 24273599 Free PMC article.
PARP inhibitors for chemoprevention--letter.
Chand SN, Blanco FF, Jimbo M, Tsangaris TN, Cristofanilli M, Yeo CJ, Winter JM, Pishvaian MJ, Brody JR. Chand SN, et al. Among authors: pishvaian mj. Cancer Prev Res (Phila). 2014 Nov;7(11):1170-1. doi: 10.1158/1940-6207.CAPR-14-0220. Cancer Prev Res (Phila). 2014. PMID: 25368011 No abstract available.
Upgrading gemcitabine with recycled kinase inhibitors.
Blanco FF, Pishvaian MJ, Brody JR. Blanco FF, et al. Among authors: pishvaian mj. Cell Cycle. 2014;13(18):2810-1. doi: 10.4161/15384101.2014.954211. Cell Cycle. 2014. PMID: 25486467 Free PMC article. No abstract available.
109 results